The effects of capsaicin and mucosal acidification on gastric HCO 3 -secretion were compared in wild-type and prostacyclin (PGI 2 ) IP receptor or prostaglandin E receptor EP1 or EP3 knockout C57BL/6 mice as well as rats. Under urethane anesthesia, the stomach was mounted on an ex-vivo chamber, perfused with saline, and the secretion of HCO 3 -was measured at pH 7.0 using the pH-stat method. Capsaicin or 200 mM HCl was applied to the chamber for 10 min. Capsaicin increased the secretion of HCO 3 -in rats and wild-type mice, the response at 0.3 mg/ml being equivalent to that induced by acidification. This effect of capsaicin in rats was abolished by ablation of capsaicin-sensitive afferent neurons and attenuated by indomethacin, L-NAME and capsazepine (TRPV1 antagonist) but not 
Introduction
The gastric mucosa is kept intact by multiple protective mechanisms including humoral and neuronal factors, despite exposure to acid and other chemical hazards (Flemstrom & Garner, 1982) . Capsaicin-sensitive afferent neurons play a central role in the neuronal mechanism of the stomach (Holzer, 1998) . These afferent neurons regulate various gastric functions such as secretion, mucosal blood flow (GMBF) and motility, and modulate the mucosal integrity of the stomach (Holzer & Sametz; 1986 Holzer, 1998 Takeuchi et al., 1991; 1992) . Vanilloid type 1 receptor (VR1), a nonselective cationic channel, has been recently cloned as the binding site of capsaicin (Caterina et al., 1997) , and more recently, has been shown to be one of the transient receptor potential (TRP) family of ion channels (Clapham et al., 2001) . Although the TRP family is activated by a diverse range of stimuli, including depletion of intracellular Ca 2+ stores (Caterina et al., 1997) , the VR1 receptor remains the only channel activated by vanilloids such as capsaicin and is now known as TRPV1 (Gunthorpe et al., 2002) . Capsaicin stimulates these afferent neurons via TRPV1, resulting in the release of calcitonin gene-related peptide (CGRP), the predominant neurotransmitter of spinal afferents in the rat stomach, and by so doing exerts a gastroprotective action (Merchant et al., 1994) . CGRP acts on endothelial cells to release nitric oxide (NO) , and this molecule is also known to mediate, in large part, the action of CGRP (Holzer, 1998) . Recent studies also showed that the activation of the bradykinin B2 receptor leads to the opening of TRPV1 and modifies the action of capsaicin (Ferreira et al., 2002; Shin et al., 2004) .
The secretion of HCO 3 -from surface epithelial cells is a protective mechanism in the stomach, the HCO 3 -working in collaboration with mucus gel that adheres to the surface of mucosa (Flemstrom & Garner, 1982) . We previously reported that capsaicin increased duodenal HCO 3 -secretion mediated by endogenous prostaglandins (PGs) and JPET#87619
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NO as well as capsaicin-sensitive afferent neurons (Sugamoto et al., 2002; Kagawa et al., 2003) . We also reported that PGE 2 stimulates HCO 3 -secretion through EP1 receptors in the stomach and EP3/EP4 receptors in the duodenum (Takeuchi et al., 1997; Aoi et al., 2004) , while the action of capsaicin in the duodenum requires the presence of prostacyclin (PGI 2 ) IP receptors (Nakashima et al., 2004) . However, few studies have examined the mechanisms involved in gastric HCO 3 -secretion in response to capsaicin.
In the present study, we investigated the regulatory mechanism of capsaicin-induced gastric HCO 3 -secretion, in relation to sensory neurons, TRPV1, PGs, NO and bradykinin B2 receptors, and compared it to that of the acid-induced response. In addition, since we have found that the responses to capsaicin and acid in the duodenum differ concerning PGI 2 /IP dependency (Nakashima et al., 2004) , we also examined these responses in the stomach using mice lacking EP1-, EP3-or IP-receptors.
single injection. The doses of PGE 2 , capsaicin and NOR-3 were chosen to effectively stimulate duodenal HCO 3 -secretion (Takeuchi et al., 1997; Sugamoto et al., 2001 ) while that of bradykinin was chosen to induce vasodilation, inflammation and glucose uptake via B2
receptors (Shiuchi et al., 2002) . The secretion of HCO 3 -was also stimulated by exposure of the mucosa to 50~200 mM HCl (rat) or 50 mM HCl (mouse) for 10 min. In addition, the 
Measurement of Mucosal PGE 2 and PGI 2 Levels
The mucosal PGE 2 and PGI 2 (6-keto PGF 1 α ) levels in the stomach were measured after application of capsaicin (0.3 mg/ml) for 10 min. Thirty minutes later, the stomach was removed, weighed, and put in a tube containing 100% methanol plus 0.1 M indomethacin (Futaki et al., 1994) . Then, the samples were minced with scissors, homogenized, and centrifuged at 12000 r.p.m. for 10 min at 4˚C. The supernatant of each sample was used for measuring levels of PGE 2 and 6-keto PGF 1 α by EIA with PGE 2 -and 6-keto PGF 1 α -kits (Cayman Chemical Co., Ann Arbor, MI), respectively.
Preparation of Drugs
Drugs used were urethane (Tokyo kasei, Tokyo, Japan), capsaicin and bradykinin (Nacalai Tesque, Kyoto, Japan), prostaglandin E 2 (PGE 2 : Funakoshi, Tokyo, Japan), Tween and 80% saline, w/w: Wako, Osaka, Japan) for s.c. injection while it was suspended in a 0.5% carboxymethylcellulose solution (CMC: Nacalai Tesque) for topical application.
PGE 2 or NOR-3 was first dissolved in absolute ethanol or dimethyl sulfoxide (DMSO), respectively, and diluted with saline to the desired concentrations. Omeprazole was suspended in a 0.5% CMC solution. Other agents were dissolved in saline. Each agent was prepared immediately before use and given in a volume of 0.5 ml per 100 g body weight in the case of i.p. or s.c. administration or in a volume of 0.1 ml per 100 g body weight in the 
Statistics
Data are presented as the mean±SE from 4~8 rats or mice per group. Statistical analyses were performed using a two-tailed Dunnett's multiple comparison test, and values of p<0.05 were regarded as significant.
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Results
Effect of Capsaicin on Gastric HCO 3 -Secretion
Under urethane anesthesia, the rat stomach spontaneously secreted HCO 3 -at a steady rate of 0.2~0.4 µEq/10 min during a test period. Capsaicin (0.03~0.3 mg/ml) applied to the chamber for 10 min increased the secretion of HCO 3 -in a dose-dependent manner, and this effect was significant at the dose of 0.1 mg/ml or greater; the •HCO 3 -output at 0.1 and 0.3 mg/ml was 0.9±0.1 and 1.4±0.3 µEq/hr, respectively (Figure 1 ). In the subsequent experiments, we used capsaicin at 0.3 mg/ml. Mucosal PGE 2 and 6-keto PGF 1 α levels in the normal rat stomach were 4.9±0.7
and 5.8±0.9 ng/g tissue, respectively. Intragastric application of capsaicin (0.3 mg/ml) for 10 min did not affect the amount of PGE 2 but significantly increased that of 6-keto PGF 1 α to about 2.8-fold the control level, the value being 16.9±2.3 ng/g tissue (Figure 7 ).
Effect of PGE 2 , NOR-3 and Bradykinin on Gastric HCO 3 -Secretion
Since the response of HCO 3 -to capsaicin or acid in the stomach was attenuated by either indomethacin or L-NAME but not FR172357, it is assumed that both PGs and NO but not bradykinin are involved in the stimulatory mechanism of these agents. To further investigate the interactive role of PGs and NO in the mechanism of HCO 3 -secretion in the stomach, we examined the effects of PGE 2 , NOR-3 (NO donor) and bradykinin on the secretion, in the absence or presence of indomethacin, L-NAME or FR172357.
Intravenous administration of PGE 2 (1 mg/kg) increased the secretion of HCO 3 -in the stomach, and the • HCO 3 -output was 1.5±0.5 µEq/hr, the value being equivalent to that induced by capsaicin at 0.3 mg/ml (Figure 8) . Likewise, the NO donor NOR-3 (3 This article has not been copyedited and formatted. The final version may differ from this version. mg/ml), applied topically to the mucosa for 10 min, also increased HCO 3 -secretion, the • HCO 3 -output being 1.0±0.2 µEq/hr. Neither indomethacin, L-NAME nor FR172357
significantly affected the increase of HCO 3 -secretion in response to PGE 2 (data not shown).
Likewise, gastric HCO 3 -secretion was also stimulated by i.v. administration of bradykinin (30 µg/kg), reaching a maximal value of 160% of the basal level, though this effect was less potent than that of capsaicin or acidification and completely disappeared 1 hr (Figure 9 ).
The stimulatory effect of bradykinin on HCO 3 -was significantly antagonized by FR172357
and also attenuated by prior administration of indomethacin or L-NAME later. In addition, the stimulatory effect of bradykinin was almost totally blocked by chemical ablation of capsaicin-sensitive afferent neurons but not significantly affected by pretreatment with capsazepine.
Effect of Capsaicin on Gastric HCO 3 -Secretion in Wild-type and
IP-Receptor Knockout Mice
We previously reported the importance of PGI 2 /IP receptors in the HCO 3 -stimulatory action of capsaicin in the duodenum (Nakashima et al., 2004) . Since capsaicin also stimulated HCO 3 -secretion in the stomach, in an indomethacin-inhibitable manner, we investigated which type of prostanoid receptor is involved in the capsaicin-induced response in the stomach, using EP1-, EP3-and IP-receptor knockout mice, in comparison with that induced by mucosal acidification.
The mouse stomach spontaneously secreted HCO 3 -at a rate of 0.1~0.3 µEq/10 min. No difference was found in the rate of basal HCO 3 -secretion between wild-type mice and mice lacking EP1-, EP3-or IP-receptors. Capsaicin (0.3 mg/ml) applied to the chamber for 10 min increased gastric HCO 3 -secretion in wild-type mice, and this effect was similarly observed in EP1-or EP3-receptor knockout mice but disappeared in mice lacking 
Discussion
The gastroduodenal mucosa responds to acidification with a significant rise in the secretion of HCO 3 -which, in collaboration with mucus, contributes to the mucosal tolerance of luminal acid (Flemstrom & Garner, 1982) . We have previously reported that intraluminal application of capsaicin also stimulates the secretion of HCO 3 -in these tissues through the activation of capsaicin-sensitive afferent neurons (Takeuchi et al., 1991; 1992; Aoi et al., 2004; Nakashima et al., 2004) . The present study confirmed that both acid and capsaicin produced an increase of HCO 3 -secretion in the stomach mediated by these afferent neurons, and clearly showed the difference in their modes of action in terms of sensitivity to TRPV1 and prostanoid receptors. Furthermore, we observed the involvement of endogenous PGs and NO in the stimulatory action of capsaicin in the stomach, essentially similar to the findings in the duodenum.
TRPV1 is a nonselective cation channel responsive to proton as well as capsaicin (Caterina et al., 1997) . The binding sites of capsaicin are located at the intracellular site of the receptor protein (Jung et al., 1999) whereas the target of protons is thought to be located on the extracellular surface of the receptor protein (Jordt et al., 2000) . In the present study, when the TRPV1 antagonist capsazepine was applied to the mucosa together with capsaicin or acid, it was found that this agent completely blocked the increase in gastric -, yet it is likely that the target site of acid is different from that of capsaicin, ie., the binding site inhibitable by capsazepine. Alternatively, acid might activate these afferent neurons through acid-sensing ionic channels.
Endogenous PGs are particularly important in the local regulation of HCO 3 -secretion in the gastroduodenal mucosa. We previously found, using subtype-specific EP agonists and antagonists, that PGE 2 stimulates the secretion of HCO 3 -in the duodenum through EP3/EP4 receptors and in the stomach through EP1 receptors (Takeuchi et al., 1999; Aoi et al., 2004; Nakashima et al., 2004) . Many investigators reported that mucosal acidification increases HCO 3 -secretion in these tissues, with a concomitant rise in mucosal PGE 2 levels (Sugamoto et al., 2001; Kagawa et al., 2003; Nakashima et al., 2004) . Capsaicin also stimulated the secretion of HCO 3 -in the stomach in an indomethacin-inhibitable manner, suggesting the involvement of endogenous PGs in this action. However, capsaicin was reported to increase PGE 2 production in the duodenum but not in the stomach (Kagawa et al., 2003; Takeuchi et al., 2003) . Notwithstanding, this agent has a variety of actions in the stomach, such as mucosal protection and hyperemia, mediated by capsaicin-sensitive afferent neurons and also depending on endogenous PGs (Takeuchi et al., 1991; 1992; Boku et al., 2001 ). The present study confirmed that intragastric application of capsaicin did not increase levels of PGE 2 but significantly enhanced levels of (Takeuchi et al., 2003) . Although gastric hyperemic responses to these treatments were mitigated by capsaicin pretreatment (Holzer, 1998; Mimaki et al., 2002) , the response induced by acid required the presence of EP1 receptors (Takeuchi et al., 2002) while that evoked by capsaicin required the presence of IP receptors (Takeuchi et al., 2003) . Thus, it is not unreasonable that the presence of different prostanoid receptors is required for gastric HCO 3 -secretion in response to acid or capsaicin.
We observed that capsaicin had no effect on PGE 2 production but significantly increased PGI 2 generation in the stomach. Capsaicin-sensitive afferent neurons are known to distribute abundantly at peri-vascular sites, and the stimulation by capsaicin (2002) reported that the activation of these afferent neurons ameliorated ischemia/re-perfusion-induced liver injury by increasing hepatic blood flow and by limiting inflammatory response through enhancement of endothelial PGI 2 production and suggested that the CGRP-induced activation of both endothelial NO synthase and cyclooxygenase-1 is involved in this mechanism. It is thus possible that capsaicin increases endothelial PGI 2 production locally in the stomach when applied topically in the mucosa.
At present, the reason why capsaicin showed different effects on the production of PGE 2 and PGI 2 in the stomach remains unknown, yet there may be species or tissue differences in this action.
The present study also showed that the capsaicin-induced HCO 3 -secretion in the stomach was significantly attenuated by L-NAME, suggesting the involvement of endogenous NO in this process, in addition to PGs. Several studies showed that CGRP, the dominant neurotransmitter of spinal afferents, had various pharmacological actions, such as vasodilation, mediated by endogenous NO (Holzer & Sametz, 1986; Holzer, 1998; Lambrecht et al., 1993) . We demonstrated in this study that the NO donor NOR-3 stimulated gastric HCO 3 -secretion, in agreement with our previous findings in the duodenum (Sugamoto et al., 2001) . Nishihara et al (2002) reported that capsaicin increased the release of CGRP and NO in the rat stomach. Although we did not measure NO release in the stomach following capsaicin treatment, it is assumed that capsaicin activates primary afferent neurons, with the assistance of PGI 2 , to liberate CGRP, which in turn stimulates NO release, resulting in an increase in gastric HCO 3 -secretion.
Bradykinin, a product of the kinin-kallikrein system often associated with The acidification was performed by exposing the mucosa to 50~200 mM HCl for 10 min.
In Fig. A , the data are presented as % of basal values and represent the mean±SE of values determined every 10 minutes from 4~6 rats. Fig. B shows total net HCO 3 -output for 1 hr after the acidification, and the data are presented as the mean±SE for 4~6 rats.
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Significant difference from control, at P<0.05. . PGE 2 and 6-keto-PGF 1 α levels in the rat stomach after mucosal application of capsaicin under urethane anesthesia. Capsaicin (0.3 mg/ml) was applied to the chamber for 10 min, the mucosa was excised 30 min later, and then both PGE 2 and 6-keto-PGF 1 α levels were measured by EIA. Data are presented as the mean±SE for 4~6 rats.
Significant difference from the corresponding control, at P<0.05. (1 mg/kg) was given i.v., while NOR-3 (3 mg/ml) was applied to the chamber for 10 min.
Data represent total net HCO 3 -output for 1 hr after the administration of PGE 2 or NOR-3
and are presented as the mean±SE for 4-5 rats.
Significant difference from control, at P<0.05. This article has not been copyedited and formatted. The final version may differ from this version.
